首页 | 本学科首页   官方微博 | 高级检索  
     

基于系统药理学对天山雪莲活性成分的预测
引用本文:闫荷露,何兰玉,应雪,李霞,徐浩伦,王亚华,张华,唐辉,陈文. 基于系统药理学对天山雪莲活性成分的预测[J]. 中国实验方剂学杂志, 2018, 24(13): 166-171
作者姓名:闫荷露  何兰玉  应雪  李霞  徐浩伦  王亚华  张华  唐辉  陈文
作者单位:新疆植物药资源利用教育部重点实验室石河子大学药学院
基金项目:国家自然科学基金项目(81760421);新疆生产建设兵团社会发展科技攻关与成果转化计划项目(2015AD007)
摘    要:目的:通过系统药理学方法预测天山雪莲的活性成分,并验证预测结果。方法:在中药系统药理学分析平台(traditional Chinese medicine systems pharmacology,TCMSP)数据库收集天山雪莲中的成分,利用类药性(druglikeness,DL)筛选出活性化合物;构建化合物-靶点、靶点-疾病分类、癌症-靶点关系图,预测天山雪莲治疗疾病的机制;磺酰罗丹明B(sulforhodamine B,SRB)比色法测定不同浓度天山雪莲注射液对非小细胞肺癌A549的抑制率,酶联免疫吸附测定法(enzymelinked immuno sorbent assay,ELISA)检测不同药物浓度处理的A549中前列腺素E2(prostaglandin E2,PGE2)的含量。结果:筛选出24种活性化合物;随药物浓度增加对A549的抑制率随之升高,抑制率在质量浓度为110 mg·L-1时最高为86.22%;不同质量浓度药物干预后,A549细胞中PGE2分泌量较无药物干预组均有不同程度的降低(P0.05)。结论:采用系统药理学方法预测了天山雪莲作用机制,通过实验验证此预测方法比较可靠,为天山雪莲药理作用的研究提供了新的研究方法。

关 键 词:系统药理学  天山雪莲  肺癌  前列腺素E2
收稿时间:2017-10-31

Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology
YAN He-lu,HE Lan-yu,YING Xue,LI Xi,XU Hao-lun,WANG Ya-hu,ZHANG Hu,TANG Hui and CHEN Wen. Prediction of Active Constituents in Saussureae Involucratae Herba Based on Systematic Pharmacology[J]. China Journal of Experimental Traditional Medical Formulae, 2018, 24(13): 166-171
Authors:YAN He-lu  HE Lan-yu  YING Xue  LI Xi  XU Hao-lun  WANG Ya-hu  ZHANG Hu  TANG Hui  CHEN Wen
Affiliation:Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China,Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China and Key Laboratory of Xinjiang Plant Resources and Utilization Under Ministry of Education, School of Pharmacy, Shihezi University, Shihezi 832000, China
Abstract:Objective: To predict the active components from Saussureae Involucratae Herba by system pharmacology, and verify the prediction results. Method: Components in Saussureae Involucratae Herba were collected through the traditional Chinese medicine systems pharmacology (TCMSP) database; then active components were screened out if the druglikeness (DL) was at least 0.18.The relation graph of compounds-targets, targets-diseases and cancers-targets were constructed, so as to find the mechanisms for treating diseases with Saussureae Involucratae Herba. Next, the inhibitory effect against A549 cells was tested by SRB method. Meanwhile, the amount of prostaglandin E2 (PGE2) in A549 cells was quantified by enzyme-linked immuno sorbent assay (ELISA) kit after the treatments with the drugs at different concentrations. Result: The 24 components were screened out, and their inhibitory rates on A549 cells increased with the rise of concentration. The highest inhibitory rate was 86.22% at the concentration of about 110 mg·L-1. Compared with non-drug treated group, the amount of cellular PGE2 was decreased to different degrees (P<0.05) after the drug treatment. Conclusion: The treatment methods of Saussureae Involucratae Herba were predicted by system pharmacology, which was demonstrated to be reliable by the experiment. Therefore, this study provides a new research method for the discovery of Saussureae Involucratae Herba pharmaceutical effects.
Keywords:system pharmacology  Saussureae Involucratae Herba  lung cancer  prostaglandin E2
本文献已被 CNKI 等数据库收录!
点击此处可从《中国实验方剂学杂志》浏览原始摘要信息
点击此处可从《中国实验方剂学杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号